Present Title & Affiliation
- Medical Oncologist, Hospital BrasÃlia – Rede Américas, BrasÃlia, Brazil
- PhD Candidate, University of BrasÃlia (UnB) – Liquid biopsy research in colorectal cancer
| Degree | Institution | Specialty | ||
|---|---|---|---|---|
Education & Training | ||||
PhD Candidate
| University of BrasÃlia (UnB) | Research in liquid biopsy for colorectal cancer | ||
Clinical Oncology Residency
| University of São Paulo (ICESP–FMUSP) | Chief Resident (2024–2025) | ||
Internal Medicine Residency
| University of São Paulo (HCFMRP–USP) | Residency completion | ||
MD
| University of BrasÃlia (UnB) | GPA 4.97/5 | ||
Exchange Program
| Queen Mary University of London (QMUL) | Biomedical Sciences, Outstanding Academic Achievement Award | ||
Honors & Awards | ||||
International Development and Education Award (IDEA)
| ASCO | |||
Conquer Cancer Merit Award
| ASCO | |||
Resident of the Year
| University of São Paulo (USP) | |||
ASCO In-Training Exam – Highest Score
| ASCO | |||
Outstanding Academic Achievement Award
| QMUL – Science Without Borders | |||
Best Oral Presentation – Undergraduate Project
| Brazilian Congress of Cardiology | |||
Honorable Mention
| 10th Scientific Initiation Congress, Federal District | |||
Professional Experience | ||||
Medical Oncologist
| Hospital BrasÃlia – Rede Américas | BrasÃlia, Brazil | ||
Clinical Researcher (Sub-Investigator)
| L2IP Institute of Clinical Research | Brazil | ||
Medical Doctor – Second Lieutenant
| Brazilian Army, HMAB | BrasÃlia, Brazil | ||
Society Memberships | ||||
Brazilian Society of Clinical Oncology (SBOC)
| Member | |||
European Society for Medical Oncology (ESMO)
| Member | |||
American Society of Clinical Oncology (ASCO)
| Member | |||
Selected Publications | ||||
Induction chemotherapy + chemoradiotherapy for LACC — Systematic review & meta-analysis
| Cancer Treatment Reviews, 2025 | |||
Pembrolizumab + chemo in TNBC — Neo-Real/GBECAM0123
| Breast, 2025 | |||
Visceral crisis in metastatic breast cancer — 15-year real-world cohort
| eCancerMedicalScience, 2025 | |||
CDK4/6 inhibitors in HR+ HER2- breast cancer
| Expert Review of Anticancer Therapy, 2025 | |||
Immune-related adverse events in early TNBC with pembrolizumab
| Breast, 2025 | |||
Real-world nasopharyngeal carcinoma induction chemotherapy
| eCancer, 2025 | |||
AIP p.(Arg304Gln) variant in pituitary tumorigenesis
| European Journal of Endocrinology, 2025 | |||
Doege-Potter syndrome related to solitary fibrous tumor
| Autopsy & Case Reports, 2022 | |||
Malignant pheochromocytoma — 18-year survival case
| Archives of Endocrinology Metabolism, 2018 | |||
TBG deficiency due to SERPINA7 mutation
| Gene, 2018 | |||
Prosthetic valve endocarditis management
| São Paulo Medical Journal, 2018 | |||